Changes in the Gut Microbiome Associated with Intussusception in Patients with Peutz-Jeghers Syndrome/Experiment 4

From BugSigDB


Needs review

Curated date: 2024/03/19

Curator: Rahila

Revision editor(s): Rahila

Subjects

Location of subjects
China
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Feces Cow dung,Cow pat,Droppings,Dung,Excrement,Excreta,Faeces,Fecal material,Fecal matter,Fewmet,Frass,Guano,Matières fécales@fr,Merde@fr,Ordure,Partie de la merde@fr,Piece of shit,Porción de mierda@es,Portion of dung,Portion of excrement,Portion of faeces,Portion of fecal material,Portion of fecal matter,Portion of feces,Portion of guano,Portion of scat,Portionem cacas,Scat,Spoor,Spraint,Stool,Teil der fäkalien@de,Feces,feces
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Peutz-Jeghers Polyp Peutz Jeghers polyp,Peutz-Jeghers polyp,Peutz-Jeghers Polyp,peutz-Jeghers Polyp
Group 0 name Corresponds to the control (unexposed) group for case-control studies
Without Intussusception (NI-PJS)
Group 1 name Corresponds to the case (exposed) group for case-control studies
With Intussusception (I-PJS)
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Patients who had undergone at least one intussusception (I-PJS)
Group 0 sample size Number of subjects in the control (unexposed) group
26
Group 1 sample size Number of subjects in the case (exposed) group
35
Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
within 3 months

Lab analysis

Sequencing type
WMS
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
Not specified
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
relative abundances
Statistical test
LEfSe
Mann-Whitney (Wilcoxon)
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
Yes
LDA Score above Threshold for the linear discriminant analysis (LDA) score for studies using the popular LEfSe tool
2.0


Signature 1

Needs review

Curated date: 2024/03/19

Curator: Rahila

Revision editor(s): Rahila

Source: FIG 4 (D)

Description: LEfSe analysis showed the differential species between I-PJS and NI-PJS patients (LDA > 2.0).

Abundance in Group 1: increased abundance in With Intussusception (I-PJS)

NCBI Quality ControlLinks
Aeromonas veronii
Collinsella sp. AF08-23
Dialister invisus CAG:218
Fusobacterium necrogenes
Fusobacterium sp.
unclassified Aeromonas
bacterium 1xD8-27

Revision editor(s): Rahila

Signature 2

Needs review

Curated date: 2024/03/19

Curator: Rahila

Revision editor(s): Rahila

Source: FIG 4 (D)

Description: LEfSe analysis showed the differential species between I-PJS and NI-PJS patients (LDA > 2.0).

Abundance in Group 1: decreased abundance in With Intussusception (I-PJS)

NCBI Quality ControlLinks
Faecalibacterium prausnitzii
unclassified Faecalibacterium
Faecalibacterium sp.
Faecalibacterium sp. CAG:74_58_120
Prevotella sp. AM42-24
Alistipes senegalensis
unclassified Flavobacteriaceae
Coprobacter fastidiosus
Faecalibacterium sp. AF10-46
Haemophilus parainfluenzae

Revision editor(s): Rahila